Teleflex Incorporated (NYSE:TFX) Shares Sold by Nuveen Asset Management LLC

Nuveen Asset Management LLC trimmed its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 7.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 148,030 shares of the medical technology company's stock after selling 12,757 shares during the period. Nuveen Asset Management LLC owned approximately 0.32% of Teleflex worth $26,346,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also made changes to their positions in the company. Vontobel Holding Ltd. lifted its stake in shares of Teleflex by 21.9% during the 4th quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company's stock worth $248,000 after acquiring an additional 250 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Teleflex by 5.2% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company's stock worth $19,263,000 after acquiring an additional 5,322 shares during the period. Lecap Asset Management Ltd. acquired a new stake in Teleflex during the fourth quarter worth about $729,000. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Teleflex by 35.1% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company's stock worth $1,053,000 after acquiring an additional 1,527 shares during the period. Finally, Boston Trust Walden Corp lifted its holdings in Teleflex by 3.9% during the fourth quarter. Boston Trust Walden Corp now owns 294,614 shares of the medical technology company's stock valued at $52,435,000 after purchasing an additional 11,052 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Raymond James downgraded Teleflex from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. Bank of America cut Teleflex from a "neutral" rating to an "underperform" rating and lowered their price objective for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. Wall Street Zen cut shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Mizuho set a $155.00 target price on shares of Teleflex in a report on Wednesday, April 16th. Finally, Royal Bank of Canada lowered their target price on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a report on Friday, May 2nd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Teleflex presently has a consensus rating of "Hold" and a consensus target price of $164.63.

Teleflex Trading Down 0.6%

TFX stock traded down $0.74 on Wednesday, hitting $122.22. 33,199 shares of the company were exchanged, compared to its average volume of 931,928. The stock has a market capitalization of $5.40 billion, a price-to-earnings ratio of 24.30, a price-to-earnings-growth ratio of 1.73 and a beta of 1.17. The business's fifty day moving average is $130.74 and its two-hundred day moving average is $158.78. Teleflex Incorporated has a twelve month low of $119.08 and a twelve month high of $249.90. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.88 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $700.67 million for the quarter, compared to analyst estimates of $699.37 million. During the same period in the previous year, the company posted $3.21 EPS. Teleflex's revenue for the quarter was down 5.0% on a year-over-year basis. As a group, research analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.11%. The ex-dividend date is Tuesday, May 20th. Teleflex's payout ratio is currently 42.90%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.